Literature DB >> 8945536

Lung phagocyte bactericidal function in strains of mice resistant and susceptible to Pseudomonas aeruginosa.

C Morissette1, C Francoeur, C Darmond-Zwaig, F Gervais.   

Abstract

The host response to Pseudomonas aeruginosa lung infection varies among inbred mouse strains. Mice of the BALB/c strain are resistant to P. aeruginosa lung infection, whereas mice of the DBA/2 strain are susceptible. This phenotypic variation correlates with a difference in the magnitude of the inflammatory response induced early following infection. In order to determine whether the ability of lung phagocytic cells to kill P. aeruginosa plays a role in the host response to the infection, we measured the in vitro bactericidal activity of resident and inflammatory alveolar and interstitial macrophages, using a temperature-sensitive mutant of P. aeruginosa. Lung macrophages obtained from resistant and susceptible animals displayed similar bactericidal activities, suggesting that the ability of phagocytes to kill P. aeruginosa does not play a crucial role in the outcome of infection. The bactericidal activity of lung phagocytes was also assessed in vivo following endobronchial infection with the temperature-sensitive mutant of P. aeruginosa. Resistant mice showed a rapid influx of polymorphonuclear leukocytes (PMNs) to the bronchoalveolar space which was shortly followed by an efficient clearance of the bacteria. Susceptible mice had a delay in both the inflammatory response to P. aeruginosa and the initiation of bacterial clearance. Susceptible mice have been shown to have a defect in tumor necrosis factor alpha production when infected intratracheally with P. aeruginosa. Intratracheal instillation of tumor necrosis factor alpha to susceptible mice at the time of infection significantly improved the recruitment of PMNs to the site of infection without affecting the process of bacterial clearance. Overall, these results suggest that both recruitment of a high number of PMNs to the lungs and an efficient activation process of the phagocytes are crucial for the prompt clearance of P. aeruginosa.

Entities:  

Mesh:

Year:  1996        PMID: 8945536      PMCID: PMC174478          DOI: 10.1128/iai.64.12.4984-4992.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

Review 1.  Pathogenesis of cystic fibrosis.

Authors:  C Koch; N Høiby
Journal:  Lancet       Date:  1993-04-24       Impact factor: 79.321

Review 2.  Recombinant cytokines and pulmonary host defense.

Authors:  J K Kolls; S Nelson; W R Summer
Journal:  Am J Med Sci       Date:  1993-11       Impact factor: 2.378

3.  [The study of pathogenic mechanisms of chronic Pseudomonas aeruginosa lung infections by mucoid strains].

Authors:  A Ohno; S Miyazaki; K Tateda; Y Kaneko; N Huruya; A Tsuji; K Yamaguchi; S Goto
Journal:  Kansenshogaku Zasshi       Date:  1992-03

4.  Mouse pleural macrophages: characterization and comparison with mouse alveolar and peritoneal macrophages.

Authors:  A Zlotnik; A Vatter; R L Hayes; E Blumenthal; A J Crowle
Journal:  J Reticuloendothel Soc       Date:  1982-03

5.  Pulmonary immunity to Pseudomonas aeruginosa in intestinally immunized rats roles of alveolar macrophages, tumor necrosis factor alpha, and interleukin-1 alpha.

Authors:  A Buret; M L Dunkley; G Pang; R L Clancy; A W Cripps
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

6.  Correlation between genotype and phenotype in patients with cystic fibrosis.

Authors: 
Journal:  N Engl J Med       Date:  1993-10-28       Impact factor: 91.245

7.  Treatment of murine macrophages with murine interferon-gamma and tumour necrosis factor-alpha enhances uptake and intracellular killing of Pseudomonas aeruginosa.

Authors:  S S Pierangeli; G Sonnenfeld
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

8.  The effect of treatment with interleukin-1 and tumor necrosis factor on Pseudomonas aeruginosa lung infection in a granulocytopenic mouse model.

Authors:  C R Amura; P A Fontan; N Sanjuan; D O Sordelli
Journal:  Clin Immunol Immunopathol       Date:  1994-11

9.  Anti-tumor necrosis factor antibodies inhibit the influx of granulocytes and monocytes into an inflammatory exudate and enhance the growth of Listeria monocytogenes in various organs.

Authors:  R van Furth; T L van Zwet; A M Buisman; J T van Dissel
Journal:  J Infect Dis       Date:  1994-07       Impact factor: 5.226

Review 10.  Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis.

Authors:  S S Pedersen
Journal:  APMIS Suppl       Date:  1992
View more
  30 in total

1.  Route and type of nutrition influence mucosal immunity to bacterial pneumonia.

Authors:  B K King; K A Kudsk; J Li; Y Wu; K B Renegar
Journal:  Ann Surg       Date:  1999-02       Impact factor: 12.969

2.  In vivo discrimination of type 3 secretion system-positive and -negative Pseudomonas aeruginosa via a caspase-1-dependent pathway.

Authors:  Tamding Wangdi; Lilia A Mijares; Barbara I Kazmierczak
Journal:  Infect Immun       Date:  2010-09-07       Impact factor: 3.441

3.  Pseudolipasin A is a specific inhibitor for phospholipase A2 activity of Pseudomonas aeruginosa cytotoxin ExoU.

Authors:  Vincent T Lee; Stefan Pukatzki; Hiromi Sato; Eriya Kikawada; Anastasia A Kazimirova; Jin Huang; Xiaohua Li; Jonathan P Arm; Dara W Frank; Stephen Lory
Journal:  Infect Immun       Date:  2006-12-18       Impact factor: 3.441

Review 4.  Natural pathogens of laboratory mice, rats, and rabbits and their effects on research.

Authors:  D G Baker
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

5.  Quantitative and qualitative differences in bronchoalveolar inflammatory cells in Pseudomonas aeruginosa-resistant and -susceptible mice.

Authors:  K Sapru; P K Stotland; M M Stevenson
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

6.  Proinflammatory cytokine deficiency and pathogenesis of Pseudomonas aeruginosa keratitis in aged mice.

Authors:  J A Hobden; S A Masinick; R P Barrett; L D Hazlett
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

7.  Defect in early lung defence against Pseudomonas aeruginosa in DBA/2 mice is associated with acute inflammatory lung injury and reduced bactericidal activity in naive macrophages.

Authors:  Kari R Wilson; Jennifer M Napper; James Denvir; Vincent E Sollars; Hongwei D Yu
Journal:  Microbiology       Date:  2007-04       Impact factor: 2.777

8.  Role of the Fas pathway in Pseudomonas aeruginosa keratitis.

Authors:  Zimei Zhou; Minhao Wu; Ronald P Barrett; Sharon A McClellan; Yunfan Zhang; Linda D Hazlett
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-12-17       Impact factor: 4.799

9.  Faster activation of polymorphonuclear neutrophils in resistant mice during early innate response to Pseudomonas aeruginosa lung infection.

Authors:  P Ø Jensen; C Moser; O Kobayashi; H P Hougen; A Kharazmi; N Høiby
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

10.  Resistance to Pseudomonas aeruginosa chronic lung infection requires cystic fibrosis transmembrane conductance regulator-modulated interleukin-1 (IL-1) release and signaling through the IL-1 receptor.

Authors:  Nina Reiniger; Martin M Lee; Fadie T Coleman; Christopher Ray; David E Golan; Gerald B Pier
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.